EcoDrugPlus

Adrenoceptor Alpha 1d

Ensembl ID : ENSPNYG00000022630
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPNYG00000001996
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSPNYG00000004800
Gene Symbol: ADRA2A
3 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSPNYG00000009304
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPNYG00000006662
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSPNYG00000005979
Gene Symbol: ADRA2C
2 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSPNYG00000001797
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSPNYG00000016532
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSPNYG00000000164
Gene Symbol: ADRB2
3 Cross references
195 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSPNYG00000007804
Gene Symbol: LOC102193239
3 Cross references
343 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSPNYG00000007832
Gene Symbol: LOC102193524
3 Cross references
345 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSPNYG00000017172
Gene Symbol: LOC102194112
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).